Human papillomavirus vaccine (Virionics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman papillomavirus vaccine (Virionics)
Drug Alias NamePapViRxCVLP tumour vaccine-MediGene/VirionicsHPV-16 L1-E7 chimeric VLP-MediGene/VirionicsHuman papillomavirus type 16 L1-E7 chimeric virus-like particle vaccine-MediGene/Virionics
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAnal intraepithelial neoplasiaVulvar NeoplasmsUterine Cervical Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesMedigene Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVirionicsMedigene Ag
Active IndicationsN/A
Inactive IndicationsAnal intraepithelial neoplasiaVulvar NeoplasmsUterine Cervical Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A